Recently, researchers have reported that FSTL1 up-regulates the BMP4-Smad signaling in lung adenocarcinoma (11), while in glioblastoma, FSTL1 down-regulates the same signaling (21). This evidence concerns the gene FSTL1 and lung adenocarcinoma.